Immune function in chronic active Epstein-Barr virus infection
- 1 January 1985
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 5 (1), 46-54
- https://doi.org/10.1007/bf00915168
Abstract
The spectrum of illness attributed to Epstein-Barr virus (EBV) includes patients with symptoms persisting for more than 1 year without any other obvious underlying disease. High titers of antibodies to EBV, either IgG anti-viral capsid antigen or anti-early antigen, can be demonstrated. In this study, 13 patients diagnosed as having chronic active EBV infection were examined to determine aspects of their immunologic status. Morphological examination and fluorescent antibody analysis revealed no abnormalities in the phenotypes of peripheral blood white cells present in these patients. Compared to those from healthy control individuals, mononuclear cells from the patients showed a markedly depressed ability to produce both interleukin-2 and interferon after stimulation with mitogen and a phorbol ester. Studies of natural killer (NK) cell activity revealed that unfractionated mononuclear cells from patients with chronic active EBV infection were significantly lower in killing activity compared to the control group. Fractionation procedures to enrich for large granular lymphocytes resulted in an increase in NK activity for all individuals, but killing activity still remained slightly lower in the patients than in the control group. The dysfunctions which were found in patients with chronic active EBV infection may reflect a primary defect in natural immune functions of the patients predisposing them to a chronic or intermittent clinical disease rather than a self-limiting illness. Alternatively, the abnormalities detected in these experiments may be a result of the viral infection itself.Keywords
This publication has 35 references indexed in Scilit:
- Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosisClinical Immunology and Immunopathology, 1984
- Evidence for suppressor T-cell regulation of human gamma interferon productionCellular Immunology, 1983
- Suppressor cells of the human NK activity: Characterization of the cells and mechanism of actionCellular Immunology, 1983
- X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.Journal of Clinical Investigation, 1983
- Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal TransplantationNew England Journal of Medicine, 1983
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptorsCellular Immunology, 1983
- EPSTEIN-BARR-VIRUS-INDUCED LYMPHOPROLIFERATIVE DISORDER CONVERTING TO FATAL BURKITT-LIKE LYMPHOMA IN A BOY WITH INTERFERON- INDUCIBLE CHROMOSOMAL DEFECTThe Lancet, 1980
- Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious MononucleosisNew England Journal of Medicine, 1979
- Epstein-Barr herpesvirus infection: Inhibition by immunologically induced mediators with interferon-like propertiesInternational Journal of Cancer, 1977
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973